Original Research
Published on 14 Aug 2020
ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
in Genomic Medicine
Frontiers in Genetics
doi 10.3389/fgene.2020.00933
- 11,086 views
- 46 citations




